lamivudine has been researched along with deoxyguanosine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cane, PA; Mutimer, D; Pillay, D | 1 |
Addison, WR; Allen, MI; Condreay, LD; Tipples, GA; Tyrrell, L; Walters, KA | 1 |
Belsey, E; Berzins, B; Chen, D; Choi, J; da Silva, B; Gerschenson, M; Kim, C; Libutti, DE; McComsey, GA; Murphy, RL; Shore, J; Taiwo, B; Weinstein, J | 1 |
3 other study(ies) available for lamivudine and deoxyguanosine
Article | Year |
---|---|
Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Deoxyguanosine; Famciclovir; Hepatitis B; HIV Infections; Humans; Lamivudine | 1999 |
Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
Topics: Acyclovir; Antiviral Agents; Base Sequence; Deoxyguanosine; Dideoxynucleosides; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Transfection; Tumor Cells, Cultured; Virus Replication | 2003 |
Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenine; Adipose Tissue; Adult; Anti-HIV Agents; Body Fat Distribution; CD4 Lymphocyte Count; Deoxyguanosine; F2-Isoprostanes; Glutathione; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Mitochondria; Organophosphonates; Pyrimidinones; Ritonavir; Stavudine; Tenofovir; Treatment Outcome; Viral Load | 2009 |